MedTrace Logo

Identification of Biomarkers for Early Detection of Pancreatic Cancer

NCT00897494 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2016-03-09

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is examining blood samples from patients with cancer to identify biomarkers that may help in the early detection of pancreatic cancer.

Conditions

Interventions

GENETIC

protein expression analysis

Venous blood collection

OTHER

laboratory biomarker analysis

Venous blood collection

OTHER

mass spectrometry

Venous blood collection

OTHER

surface-enhanced laser desorption/ionization-time of flight mass spectrometry

Venous blood collection

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Barbara Ann Karmanos Cancer Institute

    lead OTHER

Principal Investigators

  • Fazlul Sarkar, MD · Barbara Ann Karmanos Cancer Institute

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2009-11-30
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897494 on ClinicalTrials.gov